vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and UNIVERSAL DISPLAY CORP \PA\ (OLED). Click either name above to swap in a different company.
ACADIA PHARMACEUTICALS INC is the larger business by last-quarter revenue ($284.0M vs $142.2M, roughly 2.0× UNIVERSAL DISPLAY CORP \PA\). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs 25.2%, a 71.1% gap on every dollar of revenue. On growth, ACADIA PHARMACEUTICALS INC posted the faster year-over-year revenue change (9.4% vs -14.5%). Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (17.5% CAGR vs -5.3%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
Universal Display Corporation is a developer and manufacturer of organic light emitting diode (OLED) technologies and materials, and it is a provider of services to the display and lighting industries.
ACAD vs OLED — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $284.0M | $142.2M |
| Net Profit | $273.6M | $35.9M |
| Gross Margin | 90.8% | 74.6% |
| Operating Margin | 6.1% | 30.1% |
| Net Margin | 96.3% | 25.2% |
| Revenue YoY | 9.4% | -14.5% |
| Net Profit YoY | 90.3% | -44.3% |
| EPS (diluted) | $1.61 | $0.76 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $142.2M | ||
| Q4 25 | $284.0M | $172.9M | ||
| Q3 25 | $278.6M | $139.6M | ||
| Q2 25 | $264.6M | $171.8M | ||
| Q1 25 | $244.3M | $166.3M | ||
| Q4 24 | $259.6M | $162.3M | ||
| Q3 24 | $250.4M | $161.6M | ||
| Q2 24 | $242.0M | $158.5M |
| Q1 26 | — | $35.9M | ||
| Q4 25 | $273.6M | $66.3M | ||
| Q3 25 | $71.8M | $44.0M | ||
| Q2 25 | $26.7M | $67.3M | ||
| Q1 25 | $19.0M | $64.4M | ||
| Q4 24 | $143.7M | $46.0M | ||
| Q3 24 | $32.8M | $66.9M | ||
| Q2 24 | $33.4M | $52.3M |
| Q1 26 | — | 74.6% | ||
| Q4 25 | 90.8% | 76.1% | ||
| Q3 25 | 92.2% | 74.6% | ||
| Q2 25 | 92.2% | 77.2% | ||
| Q1 25 | 91.7% | 77.1% | ||
| Q4 24 | 91.6% | 77.0% | ||
| Q3 24 | 92.5% | 77.8% | ||
| Q2 24 | 92.5% | 75.8% |
| Q1 26 | — | 30.1% | ||
| Q4 25 | 6.1% | 38.9% | ||
| Q3 25 | 12.8% | 30.9% | ||
| Q2 25 | 12.2% | 39.9% | ||
| Q1 25 | 7.9% | 41.9% | ||
| Q4 24 | 59.1% | 32.3% | ||
| Q3 24 | 12.6% | 41.5% | ||
| Q2 24 | 12.6% | 35.6% |
| Q1 26 | — | 25.2% | ||
| Q4 25 | 96.3% | 38.4% | ||
| Q3 25 | 25.8% | 31.5% | ||
| Q2 25 | 10.1% | 39.2% | ||
| Q1 25 | 7.8% | 38.8% | ||
| Q4 24 | 55.4% | 28.4% | ||
| Q3 24 | 13.1% | 41.4% | ||
| Q2 24 | 13.8% | 33.0% |
| Q1 26 | — | $0.76 | ||
| Q4 25 | $1.61 | $1.40 | ||
| Q3 25 | $0.42 | $0.92 | ||
| Q2 25 | $0.16 | $1.41 | ||
| Q1 25 | $0.11 | $1.35 | ||
| Q4 24 | $0.86 | $0.96 | ||
| Q3 24 | $0.20 | $1.40 | ||
| Q2 24 | $0.20 | $1.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $177.7M | $516.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.2B | — |
| Total Assets | $1.6B | $1.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $516.4M | ||
| Q4 25 | $177.7M | $602.4M | ||
| Q3 25 | $258.0M | $603.0M | ||
| Q2 25 | $253.6M | $525.2M | ||
| Q1 25 | $217.7M | $571.3M | ||
| Q4 24 | $319.6M | $492.7M | ||
| Q3 24 | $155.1M | $551.6M | ||
| Q2 24 | $177.1M | $530.5M |
| Q1 26 | — | — | ||
| Q4 25 | $1.2B | $1.8B | ||
| Q3 25 | $917.3M | $1.7B | ||
| Q2 25 | $822.4M | $1.7B | ||
| Q1 25 | $765.2M | $1.7B | ||
| Q4 24 | $732.8M | $1.6B | ||
| Q3 24 | $577.2M | $1.6B | ||
| Q2 24 | $516.7M | $1.5B |
| Q1 26 | — | $1.9B | ||
| Q4 25 | $1.6B | $2.0B | ||
| Q3 25 | $1.3B | $1.9B | ||
| Q2 25 | $1.2B | $1.9B | ||
| Q1 25 | $1.1B | $1.9B | ||
| Q4 24 | $1.2B | $1.8B | ||
| Q3 24 | $976.9M | $1.8B | ||
| Q2 24 | $914.1M | $1.8B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.7M | $108.9M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | -0.18× | 3.03× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $108.9M | ||
| Q4 25 | $-48.7M | $31.1M | ||
| Q3 25 | $74.3M | $97.2M | ||
| Q2 25 | $64.0M | $51.9M | ||
| Q1 25 | $20.3M | $30.6M | ||
| Q4 24 | $40.4M | $34.7M | ||
| Q3 24 | $63.2M | $79.9M | ||
| Q2 24 | $25.0M | $67.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | $15.1M | ||
| Q3 25 | $73.9M | $84.3M | ||
| Q2 25 | — | $37.5M | ||
| Q1 25 | — | $17.5M | ||
| Q4 24 | — | $22.0M | ||
| Q3 24 | $63.2M | $66.2M | ||
| Q2 24 | — | $57.9M |
| Q1 26 | — | — | ||
| Q4 25 | — | 8.7% | ||
| Q3 25 | 26.5% | 60.4% | ||
| Q2 25 | — | 21.8% | ||
| Q1 25 | — | 10.5% | ||
| Q4 24 | — | 13.6% | ||
| Q3 24 | 25.2% | 41.0% | ||
| Q2 24 | — | 36.5% |
| Q1 26 | — | — | ||
| Q4 25 | — | 9.3% | ||
| Q3 25 | 0.1% | 9.2% | ||
| Q2 25 | — | 8.4% | ||
| Q1 25 | — | 7.9% | ||
| Q4 24 | — | 7.8% | ||
| Q3 24 | 0.0% | 8.4% | ||
| Q2 24 | — | 5.8% |
| Q1 26 | — | 3.03× | ||
| Q4 25 | -0.18× | 0.47× | ||
| Q3 25 | 1.03× | 2.21× | ||
| Q2 25 | 2.40× | 0.77× | ||
| Q1 25 | 1.07× | 0.47× | ||
| Q4 24 | 0.28× | 0.75× | ||
| Q3 24 | 1.93× | 1.19× | ||
| Q2 24 | 0.75× | 1.28× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACAD
| Nuplazid | $174.4M | 61% |
| Daybue | $109.6M | 39% |
OLED
| Material sales | $83.7M | 59% |
| Royalty and license fees | $54.2M | 38% |
| Contract research services | $4.3M | 3% |
